5ENN
The crystal structure of Human VPS34 in complex with a selective and potent inhibitor
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | ALS BEAMLINE 5.0.2 |
| Synchrotron site | ALS |
| Beamline | 5.0.2 |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2012-05-10 |
| Detector | ADSC QUANTUM 315r |
| Wavelength(s) | 1.0 |
| Spacegroup name | P 21 21 21 |
| Unit cell lengths | 113.726, 114.481, 143.903 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 48.010 - 2.700 |
| R-factor | 0.1749 |
| Rwork | 0.173 |
| R-free | 0.20070 |
| Structure solution method | MOLECULAR REPLACEMENT |
| RMSD bond length | 0.010 |
| RMSD bond angle | 1.120 |
| Data reduction software | HKL-2000 |
| Data scaling software | Aimless |
| Phasing software | PHASER |
| Refinement software | BUSTER (2.11.6) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 48.010 | 48.010 | 2.690 |
| High resolution limit [Å] | 2.550 | 8.070 | 2.550 |
| Rmerge | 0.023 | 0.570 | |
| Rpim | 0.012 | 0.282 | |
| Total number of observations | 9569 | 44368 | |
| Number of reflections | 61540 | ||
| <I/σ(I)> | 15.1 | 34 | 2.5 |
| Completeness [%] | 99.6 | 98.6 | 99.4 |
| Redundancy | 4.8 | 4.6 | 5 |
| CC(1/2) | 0.999 | 0.769 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 7.5 | 291.15 | 200nL:200nL well to protein 0.2M Sodium Acetate 0.1M HEPES 7.5 20% PEG 3000 |






